- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06190925
Clinical Results of Asqelio Trifocal Toric Diffractive Intraocular Lens
The goal of this observational prospective clinical study is to learn about the clinical outcomes three months after binocular implantation of Asqelio Trifocal Toric IOL in 30 patients submitted to cataract surgery following standard clinical practice. The main questions it aims to answer are: How rotationally stable is the lens after implantation and how effective is in the correction of refractive astigmatism.
Additionally, the visual performance at different distances will be assessed, as well as the patient-reported outcomes.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Alicante, Spain, 03015
- Oftalvist Alicante
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients submitted to cataract surgery with phacoemulsification with bilateral implantation of Asqelio Trifocal Toric IOL to avoid residual astigmatism
- Patient signing informed consent
- Clear intraocular media, except for cataracts in both eyes prior to surgery
- Monocular potential postoperative visual acuity of 20/25 or better
Exclusion Criteria:
- Corneal astigmatism lower than 0.75D
- Patients who do not provide informed consent
- Patients who do not understand the study procedure
- Previous corneal surgery or trauma
- Irregular cornea (e.g. keratoconus)
- Choroidal hemorrhage
- Microphtalmos
- Severe corneal dystrophy
- Uncontrolled or medically controlled glaucoma
- Clinically significant macular changes
- Concomitant severe eye disease
- Non-age-related cataract
- Severe optic nerve atrophy
- Diabetic retinopathy
- Proliferative diabetic retinopathy
- Amblyopia
- Extremely shallow anterior camera
- Severe chronic uveítis
- Pregnant or nursing
- Rubella
- Mature/dense cataract that makes it difficult to examine the fundus preoperatively.
- Previous retinal detachment
- Concurrent participation in other research with drugs or clinical devices
- Expect to require another eye surgery during the study period
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Refraction
Time Frame: 3 months after implantation
|
Manifest residual refraction after implantation of IOL using subjective refraction methods (D)
|
3 months after implantation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Corrected Visual acuity at distance
Time Frame: 3 months after implantation
|
Visual acuity at 4m with refractive correction (LogMAR units)
|
3 months after implantation
|
Corrected Visual acuity at intermediate distance
Time Frame: 3 months after implantation
|
Visual acuity at 60cm with refractive correction for distance (LogMAR units)
|
3 months after implantation
|
Corrected Visual acuity at near distance
Time Frame: 3 months after implantation
|
Visual acuity at 40cm with refractive correction for distance (LogMAR units)
|
3 months after implantation
|
Uncorrected Visual acuity at distance
Time Frame: 3 months after implantation
|
Visual acuity at 4m without correction (LogMAR units)
|
3 months after implantation
|
Uncorrected Visual acuity at intermediate distance
Time Frame: 3 months after implantation
|
Visual acuity at 60cm without correction (LogMAR units)
|
3 months after implantation
|
Uncorrected Visual acuity at near distance
Time Frame: 3 months after implantation
|
Visual acuity at 40cm without correction (LogMAR units)
|
3 months after implantation
|
Binocular defocus curve
Time Frame: 3 months after implantation
|
Defocus curve obtained in binocular conditions from +2.00D to -4.00D vergence in 0.5 steps (LogMAR units)
|
3 months after implantation
|
Rotational stability
Time Frame: 3 months after implantation
|
Change in IOL axis position determined with slit lamp (degrees)
|
3 months after implantation
|
Contrast sensitivity function
Time Frame: 3 months after implantation
|
Contrast sensitivity determined with best correction for distance, under photopic and mesopic conditions, with and without induced glare, using the Clinical Trial Suite (CTS, M&S Technologies, Niles, IL, EEUU) (Log CS units)
|
3 months after implantation
|
Patient reported outcomes - Satisfaction
Time Frame: 3 months after implantation
|
Patient reported outcomes obtained by means of the CATQuest9SF questionnaire.
9 items with 4 response options, ranging from 4 for "very great difficulty/very dissatisfied" to 1 for "no difficulty/very satisfied", and a "cannot decide" additional option, which is treated as missing data.
|
3 months after implantation
|
Patient reported outcomes - Visual Symptoms
Time Frame: 3 months after implantation
|
Patient reported outcomes on incidence and intensity of visual symptoms obtained by means of a visual symptoms questionnaire.
It explores the frequency, intensity and bothersome of 10 different and common visual symptoms.
Patients are asked to respond with 4 response options to the frequency of the symptoms, from 1 for "Never" to 4 "Very often", the intensity of the symptom, from 1 for "None" to 4 for "Severe", and the level of bothersome of the symptom, from 1 for "None" to 4 for "A lot".
|
3 months after implantation
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ASQT042021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingCataract ExtractionChina